4.8 Article

Zyxin Antagonizes the FERM Protein Expanded to Couple F-Actin and Yorkie-Dependent Organ Growth

Journal

CURRENT BIOLOGY
Volume 25, Issue 6, Pages 679-689

Publisher

CELL PRESS
DOI: 10.1016/j.cub.2015.01.010

Keywords

-

Funding

  1. Cancer Research UK (CRUK)
  2. Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BCM/121455/2010, SFRH/BD/47261/2008]
  3. Cancer Research UK [17064] Funding Source: researchfish
  4. The Francis Crick Institute [10175, 10176, 10436] Funding Source: researchfish
  5. Fundação para a Ciência e a Tecnologia [PTDC/BIA-BCM/121455/2010, SFRH/BD/47261/2008] Funding Source: FCT

Ask authors/readers for more resources

Background: Coordinated multicellular growth during development is achieved by the sensing of spatial and nutritional boundaries. The conserved Hippo (Hpo) signaling pathway has been proposed to restrict tissue growth by perceiving mechanical constraints through actin cytoskeleton networks. The actin-associated LIM proteins Zyxin (Zyx) and Ajuba (Jub) have been linked to the control of tissue growth via regulation of Hpo signaling, but the study of Zyx has been hampered by a lack of genetic tools. Results: We generated a zyx mutant in Drosophila using TALEN endonucleases and used this to show that Zyx antagonizes the FERM-domain protein Expanded (Ex) to control tissue growth, eye differentiation, and F-actin accumulation. Zyx membrane targeting promotes the interaction between the transcriptional co-activator Yorkie (Yki) and the transcription factor Scalloped (Sd), leading to activation of Yki target gene expression and promoting tissue growth. Finally, we show that Zyx's growth-promoting function is dependent on its interaction with the actin-associated protein Enabled (Ena) via a conserved LPPPP motif and is antagonized by Capping Protein (CP). Conclusions: Our results show that Zyx is a functional antagonist of Ex in growth control and establish a link between actin filament polymerization and Yki activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available